HEB – Tuesday was the PDUFA date for Ampligen, but the FDA isn’t ready to act: <a href="http://finance.yahoo.com/news/Hemispherx-Biopharma-pz-15344715.html" rel="nofollow" target="_blank">http://finance.yahoo.com/news/Hemispherx-Biopharma-pz-15344715.html</a> Amusingly, HEB shares finished the day +23% on the theory that any words from the FDA other than “get lost” should be construed as bullish.